TECNOLOGIA REGENERATIVA QREM

Startup

Information

Qrem is a start-up engaged to regenerative medicine that develops, manufactures and markets medical devices.
Its mission is to promote the standardization and scalability of autologous regenerative therapies, making available to physicians Lab-in-a-Box bioengineering systems and companion diagnostics (CDx) based on AI to carry out these therapies with high cost-effectiveness ratio.
Qrem Cytokine, the first product of the company in commercialization since 2019, obtains a Cytokine Rich Serum from the patient's blood which is infiltrated locally in the area to be treated. Currently carrying out two R&D projects based on CDx for knee osteoarthritis and prevention/cure of complex wounds.

Key Information

  • Growth Stage
    Series B
  • Country
    Spain
  • Founding Year
    2016